105
Participants
Start Date
May 14, 2021
Primary Completion Date
April 9, 2023
Study Completion Date
April 20, 2023
Placebo treatment
Active drug/placebo is given for the first 5 days of admission.
Methylnaltrexone treatment
Active drug/placebo is given for the first 5 days of admission.
Mech-Sense, Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg
Digestive Disease Center K, Bispebjerg University Hospital, Bispebjerg
Gastrounit, Hvidovre University Hospital, Hvidovre
Odense Pancreas Center, Svendborg
Odense University Hospital
OTHER
Hvidovre University Hospital
OTHER
University Hospital Bispebjerg and Frederiksberg
OTHER
Asbjørn Mohr Drewes
OTHER